CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 target
Drug / intervention
Aged Garlic Extract +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03860350
NCT03860350N/ACompleted

Aged Garlic Extract (Kyolic) Study at Lund University, Sweden

Lund University Hospital·interventional·Posted Mar 1, 2019·Updated Jun 11, 2019

In Brief

A clinical study evaluating Aged Garlic Extract and Placebo for Coronary Artery Disease and 2 related conditions. Completed, enrolled 100 participants across 1 site.

Detailed Summary

The primary intention of the study is to examine the effect of aged garlic extract (AGE) on the absolute change in coronary artery calcium (CAC). The second intention is to examine the effect of AGE on inflammatory biomarkers and microcirculation. It is a double blind placebo controlled study. The participants will ingest AGE during a period of one year. The CAC will be controlled by computer tomography (CT) scan; the inflammatory biomarkers through blood sample test and the microcirculation through laser speckel imagining and laser doppler before and after the one year period of AGE ingestion.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSweden
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMar 1, 2019
Enrollment StartDec 1, 2016
Primary CompletionJun 1, 2019
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 7.3 years ago

Interventions

Aged Garlic Extractdietary

Placebodietary